Eliglustat | compare suppliers & send inquiries for free
Dr. Reddy's Type: Producer Origin: India |  | ||
Maithri Labs. Type: Producer Origin: India | | ||
Cipla Type: Producer Origin: India | | ||
Raks Pharma Type: Producer Origin: India | |
Looking for Eliglustat 491833-29-5?
- API | Excipient name:
- Eliglustat
- Synonyms:
- Cas Number:
- 491833-29-5
- DrugBank number:
- DB09039
- Unique Ingredient Identifier:
- DR40J4WA67
About Eliglustat
What can you use it for? Eliglustat, marketed by Genzyme as CERDELGA, is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease. Patients selected for treatment with Eliglustat undergo an FDA approved genotype test to establish if they are CYP2D6 EM (extensive metabolizers), IM (intermediate metabolizers), or PM (poor metabolizers), as the results of this test dictate the dosage of Eliglustat recommended. There are no recommended dosing guidelines for CYP2D6 ultra-rapid or indeterminate metabolizers. Eliglustat was approved for use by the FDA in August 2014.
Check who is selling Eliglustat in the overview above.
Eliglustat manufacturers | traders | suppliers
We have 4 companies offering Eliglustat from 1 different countries.
Get in contact with the supplier of your choice:
- Dr. Reddy's from India
- Raks Pharma from India
- Cipla from India
- Maithri Labs. from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.